CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
89.52
+0.51 (0.57%)
At close: Nov 11, 2026, 4:00 PM EST
89.55
+0.03 (0.03%)
After-hours: Nov 11, 2026, 7:59 PM EST
CVS Health Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, CVS Health stock has a consensus rating of "Strong Buy" and an average price target of $110.32. The average 1-year stock price forecast is 23.24% higher than the current stock price, while the lowest is $86 (-3.93%) and the highest is $146 (+63.09%).
Price Target: $110.32 (+23.24%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CVS Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 18 | 18 | 18 | 18 | 18 | 18 |
| Buy | 6 | 6 | 6 | 7 | 7 | 7 |
| Hold | 4 | 4 | 3 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 28 | 28 | 27 | 27 | 27 | 28 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $100 | Buy | Maintains | $100 | +11.71% | Nov 10, 2026 |
| Raymond James | Raymond James | Buy Maintains $120 → $103 | Buy | Maintains | $120 → $103 | +15.06% | Nov 6, 2026 |
Scott Fidel Goldman Sachs | Goldman Sachs | Buy Maintains $120 → $115 | Buy | Maintains | $120 → $115 | +28.46% | Nov 6, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Nov 6, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $112 → $104 | Buy | Reiterates | $112 → $104 | +16.18% | Nov 5, 2026 |
Financial Forecast
Revenue This Year
421.72B
from 399.83B
Increased by 5.47%
Revenue Next Year
430.89B
from 421.72B
Increased by 2.17%
EPS This Year
8.26
from 6.75
Increased by 22.37%
EPS Next Year
8.67
from 8.26
Increased by 4.99%
EPS and Forward PE are based on non-GAAP adjusted numbers.